Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients - Atienza-Mateo B; Serrano-Combarro A; Loarce Martos J; Vegas-Revenga N; Martín López M; Castañeda S; Melero-González RB; Mena Vázquez N; Carrasco-Cubero C; Díez Morrondo C; Castro Corredor D; Vázquez Rodríguez TR; et al. (Seminars In Arthritis And Rheumatism, 2025)